CIP2A Antibody

CIP2A (cancerous inhibitor of PP2A) was originally identified as p90, a cytoplasmic autoantigen found in the serum from a cancer patient. It was later described as a protein that interacted with the c-myc oncogene and functioned as an inhibitor of protein phosphatase 2A (PP2A) activity. Inhibition of PP2A phosphatase activity by CIP2A prevents c-myc phosphorylation and counteracts c-myc proteolytic degradation, thereby stabilizing c-myc and promoting cell growth and transformation. CIP2A is found to be overexpressed in some human malignancies and is thus classified as an oncogene that may be an important contributor to tumor formation.
    Product/Catalog #SpecificationsPrice
    CIP2A Antibody
    A301-453A
    Reactivity: Human
    Applications: IP, IHC-P, IF
    $314.00
    Bulk Quote
    Data Sheet
    Add to Cart
    CIP2A Antibody
    A301-454A
    Reactivity: Human, Mouse, Rat
    Applications: WB, IP, IHC-P, IF
    $314.00
    Bulk Quote
    Data Sheet
    Add to Cart
    CIP2A Monoclonal Antibody
    A500-010A
    Applications: WB, IP
    Reactivity: Human
    Quantity: 0.1 ml (50-250 blots)
    $314.00
    Bulk Quote
    Data Sheet
    Add to Cart
    CIP2A Antibody AbVantage™ Pack
    A310-506A
    Applications: WB, IP, IHC-P, IF
    Reactivity: Human, Mouse, Rat
    Quantity: 1 each of A301-453A and A301-454A
    $437.00
    Bulk Quote
    Data Sheet
    Add to Cart
    CIP2A IHC Antibody
    IHC-00266
    Applications: IHC-P, IF
    Reactivity: Human
    Quantity: 0.1 ml (50 - 250 slides)
    $360.00
    Bulk Quote
    Data Sheet
    Add to Cart
    Antibodies Manufactured onclick Site
    We Make Every Antibody
    We Sell.

    Please note that Cookies and JavaScript are required for you to view this website.

    Check if you have Cookies and JavaScript enabled in your browser